Dipeptidyl Peptidase 4 Inhibitor [EPC]

This page covers all Dipeptidyl Peptidase 4 Inhibitor [EPC] drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dipeptidyl peptidase 4, 5'-AMP-activated protein kinase subunit beta-1, Solute carrier family 22 member 1, Solute carrier family 22 member 2.

Targets

Dipeptidyl peptidase 4 · 5'-AMP-activated protein kinase subunit beta-1, Solute carrier family 22 member 1, Solute carrier family 22 member 2

Marketed (10)

• Januvia · Zydus Lifesciences · Metabolic · 3200
  Januvia works by blocking an enzyme that breaks down hormones that help the body release insulin.
• Tradjenta · Boehringer Ingelheim · Metabolic · 800
  Tradjenta works by blocking the DPP-4 enzyme, which normally breaks down incretin hormones that help regulate blood sugar levels.
• Tradjenta · Boehringer Ingelheim · Metabolic · 800
  Tradjenta works by blocking an enzyme that breaks down hormones that help the body release insulin.
• Empagliflozin and Linagliptin · Institut für Pharmakologie und Präventive Medizin
• Glucophage · Generic (originally Merck Serono/Lipha) · Metabolic
  Activates AMP-activated protein kinase (AMPK) to reduce hepatic glucose production and improve insulin sensitivity without causing hypoglycemia.
• Linagliptin and Metformin · Zhujiang Hospital
• METFORMIN
• Nesina · Takeda · Metabolic
  Nesina works by blocking an enzyme that breaks down incretin hormones, allowing more insulin to be released and less glucagon.
• sitagliptin and metformin · University Medical Centre Ljubljana
• METFORMIN HYDROCHLORIDE